NUS — NU SKIN ENTERPRISES, INC.

US Healthcare Drug distribution equity mkt cap 226.3M
4.74 +1.94% today
USD · as of 2026-08-21

Price · 2024-08-26 → 2026-08-21

499 daily closes shown
52w low 4.65 · high 12.84

Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-01-04.

Performance

1 day+1.94%
1 week-1.25%
1 month-6.69%
3 months-19.80%
6 months-45.58%
Year to date-51.08%
1 year-59.69%
3 years-80.49%
5 years-91.18%

Technicals

RSI 1438.1
vs 50-day avg-7.29%
vs 200-day avg-38.33%
Volatility 1y46.8%
Max drawdown 1y-63.79%
Avg volume 30d596.8K
Daily bars held2,674
History from2016-01-04

Dividends

Yield (trailing 12m)6.45%
Paid last 12m0.3000
Payments in 12m5
Paying since2016-02-24

Measured signals that fired on NUS

datesignal measured base rate
2026-06-25Equal lows taken out
structure
-0.64% over 21 days · t = -4.75 · n = 55,661
statistically distinguishable from its control group
2026-05-08Equal lows taken out
structure
-0.64% over 21 days · t = -4.75 · n = 55,661
statistically distinguishable from its control group
2026-03-09Equal lows taken out
structure
-0.64% over 21 days · t = -4.75 · n = 55,661
statistically distinguishable from its control group

Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →

Insider transactions (Form 4)

dateinsiderwhatshares pricevalue
2026-06-10WOODBURY EDWINA D
Director
Grant or award195.43103
2026-06-02Winett James M
Director
Open-market sale 10b5-1 plan7.2K5.6240.5K
2026-06-01WOODBURY EDWINA D
Director
Open-market sale 10b5-1 plan7.2K5.7041.1K
2026-06-01CAMPBELL DANIEL W
Director
Grant or award26.6K0.000
2026-06-01WOODBURY EDWINA D
Director
Grant or award 10b5-1 plan26.6K0.000
2026-06-01Zorko Mark A
Director
Grant or award26.6K0.000
2026-06-01Winett James M
Director
Grant or award 10b5-1 plan26.6K0.000
2026-06-01Nathanson Laura
Director
Grant or award26.6K0.000
2026-06-01Thomas Pisano R.
Director
Grant or award26.6K0.000
2026-06-01Battle Emma S.
Director
Grant or award26.6K0.000

Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →

Largest institutional holders

managervalueshares
BlackRock, Inc.31.2M4.3M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC15.6M2.1M
VANGUARD CAPITAL MANAGEMENT LLC15.0M2.1M
AMERICAN CENTURY COMPANIES INC14.7M2.0M
Prescott Group Capital Management, L.L.C.13.1M1.8M
DIMENSIONAL FUND ADVISORS LP12.6M1.7M
VANGUARD PORTFOLIO MANAGEMENT LLC12.4M1.7M
RENAISSANCE TECHNOLOGIES LLC12.4M1.7M
AQR CAPITAL MANAGEMENT LLC8.9M1.2M
GEODE CAPITAL MANAGEMENT, LLC8.7M1.2M

13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →

Latest SEC filings

formfiledperiod
10-Q2026-08-102026-06-30on EDGAR ↗
8-K2026-08-102026-08-10on EDGAR ↗
42026-06-112026-06-10on EDGAR ↗
42026-06-032026-06-01on EDGAR ↗
42026-06-032026-06-01on EDGAR ↗
42026-06-032026-06-01on EDGAR ↗
42026-06-032026-06-01on EDGAR ↗
42026-06-032026-06-01on EDGAR ↗

Short selling

Avg short volume, 90d62.3% of tape
Days observed61

This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →

Recent headlines

Ask the AI about NUS

The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.

Open NUS in the terminal → How the AI works

Everything on this page is live in the terminal.

Charts, filings, insider flow and the AI — open without an account.

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →